p-[18F]-MPPF: A potential radioligand for PET studies of 5-HT(1A) receptors in humans

Synapse

Volumn 25, Issue 2, 1997, Pages 147-154

  Shiue, Chyng Yann ^a,b   Shiue, Grace G ^a   Mozley, P David ^a   Kung, Mei Ping ^a   Zhuang, Zhi Ping ^a   Kim, Hee Joung ^a   Kung, Hank F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

5 HT(1A) receptors; p 18F MPPF; PET

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (2' METHOXYPHENYL) 1 [2' [N (2'' PYRIDINYL)] 4 FLUOROBENZAMIDO]ETHYLPIPERAZINE; DIMETHYL SULFOXIDE; DRUG METABOLITE; FLUORINE 18; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; 4 (2' METHOXYPHENYL) 1 (2' (N (2'' PYRIDINYL) 4 FLUOROBENZAMIDO)ETHYL)PIPERAZINE; 4-(2' METHOXYPHENYL)-1-(2'-(N-(2''-PYRIDINYL)-4-FLUOROBENZAMIDO)ETHYL)PIPERAZINE; AMINOPYRIDINE DERIVATIVE; FLUORINE; PIPERAZINE DERIVATIVE; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HYPOTHALAMUS; IMAGE QUALITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENTAL DISEASE; MONKEY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONINERGIC SYSTEM; ANIMAL; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MACACA; METABOLISM; RADIOASSAY; SCINTISCANNING; SPRAGUE DAWLEY RAT;

AMINOPYRIDINES; ANIMALS; BRAIN; FLUORINE RADIOISOTOPES; MACACA; MALE; PIPERAZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030614929     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199702)25:2<147::AID-SYN5>3.0.CO;2-C     Document Type: Article

References (60)

1. Abramovitch, R.A. (1991) Applications of microwave energy in organic chemistry. A review. Org. Prep. Proc. Int., 23:683.
2. 1A receptors. Soc. Neurosci. 24th Annual Meeting, Miami Beach, FL, Nov. 13-18.
3. 1A receptors. J. Med. Chem., 36:1509-1510.
4. 1A receptor antagonist WAY 100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats. Eur. J. Pharmacol., 254:133-139.
5. 1A Receptors: Behavioural and Neurochemical Pharmacology, A.H. Dourish, ed. Ellis Horwood Ltd., Chichester, UK, pp. 261-278.
6. Eison, A.S., and Eison, M.S. (1994) Serotonergic mechanisms in anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry, 18:47-62.
7. 1A receptor antagonists: Utility as research tools and therapeutic agents. Trends Pharmacol. Sci., 14:441-448.
8. 1A receptors. Eur. J. Pharmacol., 237:283-291.
9. 1A receptor antagonist. Br. J. Pharmacol., 112:91.
10. Fletcher, A., Pike, V.W., and Cliffe, I.A. (1995) Visualization and characterization of 5-HT receptors and transporters in vivo and in man. Semin. Neurosci., 7:421-431.
11. Fornal, C.A., Marrosu, F., Metzler, C.W., Tada, K., and Jacobs, B.L. (1994) Effects of the putative 5-hydroxytryptamine (1A) antagonists BMY-7378, NAN-190 and (-)-propranolol on serotonergic dorsal raphe unit-activity in behaving cats. J. Pharmacol. Exp. Ther., 270:1359-1366.
12. 1A receptors. Br. J. Pharmacol., 86:601.
13. Fozard, J.R., and Saxena, P.R. (eds) (1991) Serotonin: Molecular Biology, Receptors and Functional Effects. Burkhauser Verlag, Basal,
14. Frazer, A., Maayani, S., and Wolfe, B.B. (1990) Subtypes of receptors for serotonin. Annu. Rev. Pharmacol. Toxicol., 30:307-348.
15. Glennon, R.A. (1990) Serotonin receptors: Clinical implications. Neurosci. Biobehav. Rev., 14:35-47.
16. 1A serotonin agonists and antagonists. Drug Dev. Res., 26:251-274.
17. Glennon, R.A., and Dukat, M. (1991) Serotonin receptors and their ligands: A lack of selective agents. Pharmacol. Biochem. Behav., 40:1009-1017.
18. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol., 154:339-341.
19. Gozlan, H., and Hamon, M. (1993) Pharmacology and molecular biology of central 5-HT receptors. In: Anxiety: Neurobiology, Clinic and Therapeutic Perspectives. M. Hamon, H. Ollat, and M.-H. Thiebot, eds. Colloque Inserm/John Libbey Eurotext Ltd., 141-150.
20. 1A receptors in rat brain membranes. Eur. J. Pharmacol., 288:173-186.
21. 1A receptor antagonists NAN-190 and BMY7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur. J. Pharmacol., 211:211-219.
22. Gur, R.C., Mozley, P.D., Resnick, S.M., Gottlieb, G.E., Kohn, M., Zimmerman, R., Herman, G., Atlas, S., Grossman, R., Barretta, D., Erwin, R., and Gur, R.E. (1991) Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc. Natl. Acad. Sci. USA, 88:2845-2849.
23. 1 receptors. Neuropsychopharmacology, 3:349-360.
24. 1A receptor antagonist. J. Med. Chem., 33:1541-1544.
25. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., and Humphrey, P.P.A. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46:157-203.
26. 1A receptors in rat brain. Eur. J. Pharmacol., 271:515-523.
27. Karp, J.S., Muchllehner, G., Mankoff, D.A., Ordonez, C.E., Ollinger, J.M., Danbe-Witherspoon, M.E., Haigh, A.T., and Beerbohm, D.J. (1990) Continuous-slice PENN-PET: A positron tomograph with volume imaging capability. J. Nucl. Med., 31:617-627.
28. Karp, J.S., Kinahan, P.E., Muchllehner, G., and Countryman, P. (1993) Effect of increased axial field of view on the performance of a volume PET scanner. IEEE Trans. Med. Imaging, 12:299-306.
29. 1A receptor antagonist for SPECT imaging. J. Nucl. Med., 35:93.
30. 1A receptors antagonist: p-MPPI. Life Sci., 55:1459-1462.
31. 1A receptors in rat brain. Synapse, 18:359-366.
32. A sites in rat brain: In vitro binding and autoradiographic studies. J. Pharmacol. Exp. Ther., 272:429-437.
33. 1A receptor ligands (+)-WAY 100135 and SDZ 216-525. Eur. J. Pharmacol., 249:25-35.
34. 1A receptors by [H-3]WAY 100635 in the mouse. Eur. J. Pharmacol., 271:505-514.
35. 1A receptors with positron emission tomography. Life Sci., 55:403-407.
36. 1A receptor antagonist. Eur. J. Pharmacol., 124:207-208.
37. 11C]WAY-100634 in monkey. J. Label. Compd. Radiopharm., 37:283-285.
38. Peroutka, S.J., ed (1991) In: Serotonin Receptor Subtypes - Basic and Clinical Aspects, Receptor Biochemistry and Methodology, Vol. 15. Wiley-Liss, New York,
39. Peroutka, S.J. (1994) Molecular biology of serotonin (5-HT) receptors. Synapse, 18:241-260.
40. 3H]spiroperidol. Mol. Pharmacol., 16:687-699.
41. 1A receptor of 1-aryl-4-[1-tetralin)alkyl]piperazines. 2. J. Med. Chem., 38:942-949.
42. 1A receptors in vivo. J. Nucl. Med., 36:58.
43. 1 adrenergic affinity. J. Med. Chem., 34:2633-2638.
44. 1A agonist in the treatment of major depression. Psychopharmacol. Bull., 26:169-171.
45. Resnick, S.M., Karp, J.S., Turetsky, B., and Gur, R.E. (1993) Comparison of anatomically-defined versus physiologically-based regional localization: Effects on PET-FDG quantification. J. Nucl. Med., 34:2201-2207.
46. Ritter, J.M., and Jones, T. (1995) PET: A symposium highlighting its clinical and pharmacological potential. Trends Pharmacol. Sci., 16:117-119.
47. 1A receptors. Brain Res., 532:191-196.
48. 1A receptor antagonist. Eur. J. Pharmacol., 244:251-257.
49. 1A receptor ligands in animal-models of anxiety, impulsivity and depression: Multiple mechanisms of action. Prog. Neuropsychopharmacol. Biol. Psychiatry, 17:87-104.
50. Shiue, C.-Y., Shiue, G.G., Rysavy, J.A., Pleus, R.C., Huang, H., Bai, L.-Q., Cornish, K.G., Sunderland, J.J., and Frick, M.P (1993) Fluorine-18 and carbon-11 labeled amphetamine analogs - Synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey. Nucl. Med. Biol., 20:973-981.
51. 1A receptor ligand for PET studies. J. Nucl. Med., 35:252.
52. Suranyi-Cadotte, B.E., Bodnoff, S.R., and Welner, S.A. (1990) Antidepressant-anxiolytic interactions: Involvement of the benzodiazepine-GABA and serotonin systems. Prog. Neuropsychopharmacol. Biol. Psychiatry, 14:633-654.
53. 1A receptor activation in-vivo. Life Sci., 56:163-168.
54. 1A receptor related anxiolyties. Trends Pharmacol. Sci., 8:432-437.
55. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur. J. Pharmacol., 106:271-282.
56. Whitaker-Azmitia, P.M., and Peroutka, S.J. (1990) The neuropharmacology of serotonin. Ann. N.Y. Acad. Sci., 600:1-718.
57. 1A receptor agonist, 8-OH-DPAT? Eur. J. Pharmacol., 193:253-256.
58. 1A receptor in rat and guinea pig hippocampal membranes. Eur. J. Pharmacol., 137:293-294.
59. 1A ligand. J. Med. Chem., 37:1406-1407.
60. 1A ligands. J. Med. Chem., 37:4572-4575.